Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.704 USD | +3.53% | 0.00% | -91.46% |
Apr. 11 | US Equity Markets Close Mixed After March Producer Price Inflation Data | MT |
Apr. 11 | Top Midday Decliners | MT |
Business Summary
Number of employees: 40
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marvin White
CEO | Chief Executive Officer | 62 | 16-07-31 |
Daphne Taylor
DFI | Director of Finance/CFO | 57 | 16-04-30 |
Dirk Huebner
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Jeffrey Lamothe
COO | Chief Operating Officer | 58 | 16-06-30 |
Miriam Miller
IRC | Investor Relations Contact | - | - |
SoYoung Kwon
LAW | General Counsel | 56 | 21-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marvin White
CEO | Chief Executive Officer | 62 | 16-07-31 |
Director/Board Member | 69 | 16-07-31 | |
Director/Board Member | 80 | 16-07-31 | |
John Niederhuber
CHM | Chairman | 85 | 16-02-21 |
Director/Board Member | 66 | 16-02-21 | |
Grady Grant
BRD | Director/Board Member | 68 | 16-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,594,058 | 3,590,463 ( 99.90 %) | 0 | 99.90 % |
Company contact information
Aptevo Therapeutics, Inc.
2401 4th Avenue Suite 1050
98121, Seattle
+206 838 0500
http://www.aptevotherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-91.46% | 1.09M | |
-2.10% | 103B | |
+0.77% | 95.71B | |
+1.69% | 22.02B | |
-17.09% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.94% | 15.52B | |
+3.54% | 13.86B | |
+34.36% | 12.04B |
- Stock Market
- Equities
- APVO Stock
- Company Aptevo Therapeutics Inc.